In fatal COVID-19 cases, the chemokines CXCL8, CCL2, and CCL3were significantly elevated, but they were increased similarly in mild and severe cases during the early stages of infection and remained at steady levels afterwards in the mild cases. This evidence concerns the gene CCL2 and COVID-19.